246 related articles for article (PubMed ID: 33671651)
1. sFasL-The Key to a Riddle: Immune Responses in Aging Lung and Disease.
Wallach-Dayan SB; Petukhov D; Ahdut-HaCohen R; Richter-Dayan M; Breuer R
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33671651
[TBL] [Abstract][Full Text] [Related]
2. Matrix Metalloproteinases Retain Soluble FasL-mediated Resistance to Cell Death in Fibrotic-Lung Myofibroblasts.
Nareznoi D; Konikov-Rozenman J; Petukhov D; Breuer R; Wallach-Dayan SB
Cells; 2020 Feb; 9(2):. PubMed ID: 32053892
[TBL] [Abstract][Full Text] [Related]
3. Control of ocular tumor growth and metastatic spread by soluble and membrane Fas ligand.
Gregory MS; Saff RR; Marshak-Rothstein A; Ksander BR
Cancer Res; 2007 Dec; 67(24):11951-8. PubMed ID: 18089826
[TBL] [Abstract][Full Text] [Related]
4. Cutting edge: FasL(+) immune cells promote resolution of fibrosis.
Wallach-Dayan SB; Elkayam L; Golan-Gerstl R; Konikov J; Zisman P; Dayan MR; Arish N; Breuer R
J Autoimmun; 2015 May; 59():67-76. PubMed ID: 25812467
[TBL] [Abstract][Full Text] [Related]
5. Fas ligand exerts its pro-inflammatory effects via neutrophil recruitment but not activation.
Dupont PJ; Warrens AN
Immunology; 2007 Jan; 120(1):133-9. PubMed ID: 17233740
[TBL] [Abstract][Full Text] [Related]
6. Soluble Fas ligand blocks destructive corneal inflammation in mouse models of corneal epithelial debridement and LPS induced keratitis.
Gregory-Ksander M; Perez VL; Marshak-Rothstein A; Ksander BR
Exp Eye Res; 2019 Feb; 179():47-54. PubMed ID: 30365944
[TBL] [Abstract][Full Text] [Related]
7. Role of Fas ligand in ocular tissue.
Sano Y; Sotozono C
Cornea; 2002 Mar; 21(2 Suppl 1):S30-2. PubMed ID: 11995807
[TBL] [Abstract][Full Text] [Related]
8. Membrane-bound and soluble Fas ligands have opposite functions in photoreceptor cell death following separation from the retinal pigment epithelium.
Matsumoto H; Murakami Y; Kataoka K; Notomi S; Mantopoulos D; Trichonas G; Miller JW; Gregory MS; Ksander BR; Marshak-Rothstein A; Vavvas DG
Cell Death Dis; 2015 Nov; 6(11):e1986. PubMed ID: 26583327
[TBL] [Abstract][Full Text] [Related]
9. Distinct effects of soluble and membrane-bound fas ligand on fibroblast-like synoviocytes from rheumatoid arthritis patients.
Audo R; Calmon-Hamaty F; Papon L; Combe B; Morel J; Hahne M
Arthritis Rheumatol; 2014 Dec; 66(12):3289-99. PubMed ID: 25078097
[TBL] [Abstract][Full Text] [Related]
10. The FasLane to ocular pathology-metalloproteinase cleavage of membrane-bound FasL determines FasL function.
Gregory-Ksander M; Marshak-Rothstein A
J Leukoc Biol; 2021 Nov; 110(5):965-977. PubMed ID: 33565149
[TBL] [Abstract][Full Text] [Related]
11. The evaluation of soluble Fas and soluble Fas ligand levels of bronchoalveolar lavage fluid in lung cancer patients.
Erdoğan B; Uzaslan E; Budak F; Karadağ M; Ediger D; Oral B; Göral G; Ege E; Gözü O
Tuberk Toraks; 2005; 53(2):127-31. PubMed ID: 16100648
[TBL] [Abstract][Full Text] [Related]
12. A Potential of sFasL in Preventing Gland Injury in Sjogren's Syndrome.
Luo J; Wang Y; Yu B; Qian H; He Y; Shi G
Biomed Res Int; 2017; 2017():5981432. PubMed ID: 28326325
[TBL] [Abstract][Full Text] [Related]
13. Serum soluble Fas ligand is a severity and mortality prognostic marker for COVID-19 patients.
Saleki K; Shirzad M; Javanian M; Mohammadkhani S; Alijani MH; Miri N; Oladnabi M; Azadmehr A
Front Immunol; 2022; 13():947401. PubMed ID: 36119078
[TBL] [Abstract][Full Text] [Related]
14. [Clinical significances of serum soluble fas and soluble fas ligand in chronic hepatitis B].
Jun EJ; Han JY; Sun HS
Korean J Hepatol; 2006 Dec; 12(4):507-14. PubMed ID: 17237628
[TBL] [Abstract][Full Text] [Related]
15. Overexpression of Soluble Fas Ligand following Adeno-Associated Virus Gene Therapy Prevents Retinal Ganglion Cell Death in Chronic and Acute Murine Models of Glaucoma.
Krishnan A; Fei F; Jones A; Busto P; Marshak-Rothstein A; Ksander BR; Gregory-Ksander M
J Immunol; 2016 Dec; 197(12):4626-4638. PubMed ID: 27849168
[TBL] [Abstract][Full Text] [Related]
16. Soluble form of fas and fas ligand in BAL fluid from patients with pulmonary fibrosis and bronchiolitis obliterans organizing pneumonia.
Kuwano K; Kawasaki M; Maeyama T; Hagimoto N; Nakamura N; Shirakawa K; Hara N
Chest; 2000 Aug; 118(2):451-8. PubMed ID: 10936140
[TBL] [Abstract][Full Text] [Related]
17. Soluble Fas ligand released by colon adenocarcinoma cells induces host lymphocyte apoptosis: an active mode of immune evasion in colon cancer.
Song E; Chen J; Ouyang N; Su F; Wang M; Heemann U
Br J Cancer; 2001 Sep; 85(7):1047-54. PubMed ID: 11592778
[TBL] [Abstract][Full Text] [Related]
18. Requirement of cell-cell contact in the induction of Jurkat T cell apoptosis: the membrane-anchored but not soluble form of FasL can trigger anti-CD3-induced apoptosis in Jurkat T cells.
Oyaizu N; Kayagaki N; Yagita H; Pahwa S; Ikawa Y
Biochem Biophys Res Commun; 1997 Sep; 238(2):670-5. PubMed ID: 9299572
[TBL] [Abstract][Full Text] [Related]
19. Circulating soluble Fas ligand in patients with gastric carcinoma.
Tsutsumi S; Kuwano H; Shimura T; Morinaga N; Mochiki E; Asao T
Cancer; 2000 Dec; 89(12):2560-4. PubMed ID: 11135216
[TBL] [Abstract][Full Text] [Related]
20. Soluble Fas ligand induces epithelial cell apoptosis in humans with acute lung injury (ARDS).
Matute-Bello G; Liles WC; Steinberg KP; Kiener PA; Mongovin S; Chi EY; Jonas M; Martin TR
J Immunol; 1999 Aug; 163(4):2217-25. PubMed ID: 10438964
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
